CLINICAL_TRIALS
trial_result
· 2016-07-11
Clinical Trial Update: CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1) [Phase 1]
Summary
Phase 1 drug-drug interaction study of CKD-396 (CKD-396 DDI(A) P1) has completed, providing initial safety and pharmacokinetic interaction data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Diabetes Mellitus, Type II | Phase 1 | Status: COMPLETED